글리코믹스 시장 규모, 점유율, 성장 분석 : 제품 유형별, 기술별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Glycomics Market size was valued at USD 1.7 Billion in 2024 and is poised to grow from USD 1.88 Billion in 2025 to USD 4.21 Billion by 2033, growing at a CAGR of 10.61% during the forecast period (2026-2033).

The global glycomics market is experiencing significant growth fueled by advancements in analytical technologies and an increasing acknowledgment of glycans as essential biological modulators. This field, which focuses on characterizing complex carbohydrates linked to proteins and lipids, has evolved into an integral aspect of biomedical discovery due to its influence on immunity, cell signaling, and therapeutic effectiveness. Biopharmaceutical companies are particularly driving demand for precise glycan characterization to enhance drug safety and efficacy. As mass spectrometry and bioinformatics advance, tools for glycoform profiling become more routine, supporting the rapid development and regulatory approval of biologics. Additionally, AI is transforming glycan biomarker discovery by streamlining pattern recognition, enhancing accuracy, and increasing the throughput of quality insights, ultimately broadening the application of glycomics in translational research.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Glycomics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Glycomics Market Segments Analysis

Global glycomics market is segmented by product type, technology, application, end-user and region. Based on product type, the market is segmented into Instruments, Reagents & Kits, Enzymes and Others. Based on technology, the market is segmented into Mass Spectrometry, HPLC & UHPLC, Capillary Electrophoresis, Microarray & Chip-Based Platforms, Lectin-Affinity Assays and Others. Based on application, the market is segmented into Drug Discovery & Development, Diagnostics, Academic Research, Biopharmaceutical Production, Vaccine Development and Others. Based on end-user, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations (CROs), Hospitals & Clinical Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Glycomics Market

The global glycomics market is propelled by the essential role of glycoprotein characterization in the development of biologics and regulatory evaluations. The increasing need for comprehensive glycan profiling to guarantee product quality, safety, and efficacy prompts laboratories to implement specialized workflows and platform services. This trend leads to heightened investment in analytical capabilities and fosters collaboration between research institutions and service providers. As a result, companies are expanding their commercial glycomics offerings, allowing vendors to diversify their product portfolios and enhance support for biopharmaceutical pipelines with tailored tools, methodologies, and expertise that resonate with industry demands.

Restraints in the Global Glycomics Market

The complexity of glycan analysis, which involves multiple stages such as sample preparation, derivatization, and intricate data interpretation, poses significant challenges for many laboratories that lack the requisite specialized training and multidisciplinary expertise. This reliance on specialized skills hinders the widespread adoption of glycomics, as institutions face the dual challenge of investing time and resources into workforce development or depending on external service providers, thereby restricting their capacity for in-house capabilities. Additionally, inconsistencies in methodological approaches further complicate the transfer of technology and its routine implementation, creating operational barriers that ultimately slow the integration of glycomics into standard laboratory practices.

Market Trends of the Global Glycomics Market

The Global Glycomics market is experiencing significant momentum, driven by the surging demand for customized glycosylation profiles in therapeutic biologics. This trend is propelling the innovation of therapeutic proteins, biosimilars, and novel biologics, aiming to enhance their efficacy, safety, and stability. Advances in glycoengineering techniques, such as enzymatic remodeling and site-specific conjugation, are enabling precise control over glycan structures, thereby minimizing immunogenicity and optimizing pharmacokinetics. Additionally, the rise of contract development organizations and analytical service providers is facilitating integrated glycoanalytics and process development, promoting cross-functional collaborations that streamline the journey from discovery to commercial deployment of advanced glycoengineered therapies.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Glycomics Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Instruments
• Reagents & Kits
• Enzymes
• Others

Global Glycomics Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Mass Spectrometry
• HPLC & UHPLC
• Capillary Electrophoresis
• Microarray & Chip-Based Platforms
• Lectin-Affinity Assays
• Others

Global Glycomics Market Size by Application & CAGR (2026-2033)

• Market Overview
• Drug Discovery & Development
• Diagnostics
• Academic Research
• Biopharmaceutical Production
• Vaccine Development
• Others

Global Glycomics Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organizations (CROs)
• Hospitals & Clinical Laboratories
• Others

Global Glycomics Market Size & CAGR (2026-2033)

• North America (Product Type, Technology, Application, End-User)
  • US
  • Canada
• Europe (Product Type, Technology, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Technology, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Technology, Application, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Technology, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Waters Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shimadzu
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ludger
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ProZyme
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asparia Glycomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vector Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZymeFree
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlycoDiagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• S-BIO
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RayBiotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations